If you have been reading about GLP-1 receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-27. Numbers and descriptions here follow the published literature rather than marketing material.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Includes the 39-residue backbone and the attached fatty diacid |
| Molecular weight | Approximately 4813 Da | Average mass; the monoisotopic value is slightly lower |
| Receptor targets | GIP receptor and GLP-1 receptor | Dual engagement defines the pharmacological class |
| Backbone length | 39 amino acids | Sequence modified from native glucose-dependent insulinotropic polypeptide |
| Albumin interaction | Reversible, mediated by the fatty diacid | Slows renal clearance and lengthens circulation time |
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
== See also == Scabs (disambiguation) Channeled Scablands, an eroded landscape formed by Missoula Floods in the U.S. state of Washington Scabies, a skin disease caused by the mite Sarcoptes scabiei U.S. Wheat and Barley Scab Initiative, a joint government and academic program to develop control measures to minimize the threat of Fusarium head blight (scab) in the United States
In earlier manuscript versions, the figure is surrounded by numbers and phrases which indicate where in the accompanying treatise a healer might find a particular helpful procedure. For instance, in a German Wound Man now in the Wellcome Library, London (MS 49), the spider crawling up the man's thigh is labelled "Wo eine spynne gesticht, 20" ("When a spider bites, 20"), directing the reader to paragraph 20 of the book for an appropriate cure. Similarly, written along the large spear piercing the figure's left side and penetrating into his stomach is the legend "So der gross viscus wund wirt, 14" ("If the large intestine is injured, 14"). Turning to the corresponding cure number 14, the reader finds:
=== Fertilization === Depending on the species, spermatozoa can fertilize ova externally or internally. In external fertilization, the spermatozoa fertilize the ova directly, outside of the female's sexual organs. Female fish, for example, spawn ova into their aquatic environment, where they are fertilized by the semen of the male fish. Internal fertilization occurs inside the female's sexual organs after a male inseminates a female through copulation. Most vertebrates, including amphibians, reptiles, birds and monotreme mammals, are inseminated through the cloaca. Marsupials and placental mammals are inseminated through the vagina. In macropods, semen coagulates and forms a mating plug in the vagina after copulation.
It is advised to check the references for photos of reaction results. Reagent testers might show the colour of the desired substance while not showing a different colour for a more dangerous additive. For this reason it is essential to use multiple different tests to show all adulterants.
Sources: en.wikipedia.org
Modern protective gloves called "gauntlets" continue to be worn by metal workers and welders when handling hot or molten metals or in contexts where sparks are common. These gauntlets no longer sport the metal plates of the originals, but instead are highly insulating against heat. Similar varieties of gauntlet are worn by automotive technicians to protect their hands when handling car components, and meat and fishery butchers often wear chain mail gauntlets to protect their hands from the sharp edges of knives. Motorcyclists wear gauntlets made of leather to protect their hands from abrasion during an accident, and snowmobile drivers wear fingerless gauntlets made of nylon to protect their hands from wind and cold temperatures while driving their vehicles. Falconers wear leather gauntlets to protect their hands from the sharp claws of the birds of prey that they handle, and lastly, modern competitors in fencing, particularly those competing with the épée, routinely wear fingered gauntlets to protect their hands from possible cuts and puncture wounds from their opponents' weapons.
An antagonist is a chemical that acts within the body to reduce the physiological activity of another chemical substance (such as an opiate); especially one that opposes the action on the nervous system of a drug or a substance occurring naturally in the body by combining with and blocking its nervous receptor. There are two main types of antagonist: direct-acting Antagonist and indirect-acting Antagonists:
== Vegetables == Apart from vegetables that can be commonly seen, some unique vegetables used in Chinese cuisine include baby corn, bok choy, snow peas, Chinese eggplant, Chinese broccoli, and straw mushrooms. Other vegetables, including bean sprouts, pea vine tips, watercress, lotus roots, chestnuts, water chestnuts, and bamboo shoots, are also used in different cuisines of China. Because of different climate and soil conditions, cultivars of green beans, peas, and mushrooms can be found in rich variety. A variety of dried or pickled vegetables are also processed, especially in drier or colder regions where fresh vegetables were hard to get out of season.
The Lutheran church was the state church of the Kingdom of Hanover, with the King being summus episcopus (Supreme Governor of the Lutheran Church). Regional consistories supervised church and clergy. These were in Aurich, a simultaneously Lutheran and Calvinist consistory dominated by Lutherans (for East Frisia) and the Lutheran consistories in Hanover (for the former Electorate of Brunswick-Lüneburg proper), in Ilfeld (for the County of Hohenstein, a Hanoverian exclave in the Eastern Harz mountains), in Osnabrück (for the former Prince-Bishopric of Osnabrück), in Otterndorf (existed 1535–1885 for the Land of Hadeln) as well as in Stade (existed 1650–1903, until 1885 for the former Bremen-Verden proper without Hadeln, then including the complete Stade region). A general superintendent chaired each consistory. In 1848, the Lutheran parishes were democratised by the introduction of presbyteries (German: Kirchenvorstände, singular Kirchenvorstand; literally: church boards), elected by all major male parishioners and chairing each congregation in co-operation with the pastor, being before the sole chairman. This introduction of presbyteries was somewhat revolutionary in the rather hierarchically structured Lutheran church. In 1864, Carl Lichtenberg, Hanoverian minister of education, cultural and religious affairs (1862–65), persuaded the Ständeversammlung (lit. Estates Assembly, the Hanoverian parliament) to pass a new law as to the constitution of the Lutheran church. The constitution provided a state synod (parishioners' parliament, German: Landessynode).
== History == In 1849, the French chemists Jean-François Persoz and Bloch, and the German chemist Peter Kremers (1827–?), independently first synthesized thionyl chloride by reacting phosphorus pentachloride with sulfur dioxide. However, their products were impure: both Persoz and Kremers claimed that thionyl chloride contained phosphorus, and Kremers recorded its boiling point as 100 °C (instead of 74.6 °C). In 1857, the German-Italian chemist Hugo Schiff subjected crude thionyl chloride to repeated fractional distillations and obtained a liquid which boiled at 82 °C and which he called Thionylchlorid. In 1859, the German chemist Georg Ludwig Carius noted that thionyl chloride could be used to make acid anhydrides and acyl chlorides from carboxylic acids and to make alkyl chlorides from alcohols.
Sources: en.wikipedia.org
Familial hypercholesterolemia: this disorder is characterized by the absence of functional receptors for LDL. Deficiencies in the formation of LDL receptors may cause faulty receptors which disrupt the endocytic pathway, inhibiting the entry of LDL into the liver and other cells. This causes a buildup of LDL in the blood plasma, which results in atherosclerotic plaques that narrow arteries and increase the risk of heart attacks. Lesch–Nyhan syndrome: this genetic disease is characterized by self- mutilation, mental deficiency, and gout. It is caused by the absence of hypoxanthine-guanine phosphoribosyltransferase, which is a necessary enzyme for purine nucleotide formation. The lack of enzyme reduces the level of necessary nucleotides and causes the accumulation of biosynthesis intermediates, which results in the aforementioned unusual behavior. Severe combined immunodeficiency (SCID): SCID is characterized by a loss of T cells. Shortage of these immune system components increases the susceptibility to infectious agents because the affected individuals cannot develop immunological memory. This immunological disorder results from a deficiency in adenosine deaminase activity, which causes a buildup of dATP. These dATP molecules then inhibit ribonucleotide reductase, which prevents of DNA synthesis. Huntington's disease: this neurological disease is caused from errors that occur during DNA synthesis.
== Regulation == Pyruvate dehydrogenase is inhibited when one or more of the three following ratios are increased: ATP/ADP, NADH/NAD+ and acetyl-CoA/CoA. In eukaryotes PDC is tightly regulated by its own specific Pyruvate dehydrogenase kinase (PDK) and Pyruvate dehydrogenase phosphatase (PDP), deactivating and activating it respectively.
Research into the clinical use of a recombinant form of human Activated Protein C (rhAPC) known as Drotrecogin alfa-activated, branded Xigris by Eli Lilly and Company, has been surrounded by controversy. Eli Lilly ran an aggressive marketing campaign to promote its use for people with severe sepsis and septic shock and sponsored the 2004 Surviving Sepsis Campaign Guidelines. However, a 2012 Cochrane review found that its use cannot be recommended since it does not improve survival and increases bleeding risk. In October 2011, Xigris was withdrawn from the market by Eli Lilly due to a higher mortality in a trial among adults.
=== Fragment-based === The most common of these uses a group contribution method and is termed cLogP. It has been shown that the log P of a compound can be determined by the sum of its non-overlapping molecular fragments (defined as one or more atoms covalently bound to each other within the molecule). Fragmentary log P values have been determined in a statistical method analogous to the atomic methods (least-squares fitting to a training set). In addition, Hammett-type corrections are included to account of electronic and steric effects. This method in general gives better results than atomic-based methods, but cannot be used to predict partition coefficients for molecules containing unusual functional groups for which the method has not yet been parameterized (most likely because of the lack of experimental data for molecules containing such functional groups).
In March 2020, it was announced that a secret six-month DEA operation known as "Operation Python" resulted in the arrest of 600 CJNG operatives and the seizure of $20 million in cash. The number of arrests was revised to 750, though it was still thought the CJNG could still partake in trafficking within the U.S. so long as it keeps its base of operations in Mexico. On 2 June 2020, Mexico's Financial Intelligence Unit released a statement revealing that as a result of joint operation with the DEA, the agency was able to locate "a large number of members of said criminal group, as well as its largest financial operators and companies used in money laundering". Mexico's Financial Intelligence Unit, a part of the finance ministry tasked with combating and preventing money laundering, then managed to have 1,770 bank accounts of CJNG-linked individuals frozen. Bank accounts to 16 CJNG-linked companies and two trusts linked to the CJNG were frozen as well. The move came after armed assailants stormed a live CJNG-provided concert on 29 May 2020 in the Veracruz city of Tierra Blanca, injuring two and killing six. Those killed included the regional CJNG leader, and also owner of the local El Sol de Tierra Blanca newspaper, Francisco Navarette Serna and the full lineup of La Calle, the band Serna was performing with. On 3 June, it was reported the amount of CJNG-linked assets which were frozen totaled $1.1 billion.
Sources: en.wikipedia.org
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.
Engaging two receptors recruits signaling pathways that only partly coincide. This can shift the magnitude of effects on insulin release, glucagon levels and appetite relative to selective agents. Whether the pairing delivers benefits beyond a simple sum of the two is still debated in the literature.
The proportional contribution of each receptor to observed clinical effects has not been fully separated. Long-term consequences of continuous dual stimulation are likewise unclear. Investigators continue to probe these points through laboratory and clinical work.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.